BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

474 related articles for article (PubMed ID: 24138046)

  • 21. Endolymphatic sac tumors in patients with and without von Hippel-Lindau disease: the role of genetic mutation, von Hippel-Lindau protein, and hypoxia inducible factor-1alpha expression.
    Jensen RL; Gillespie D; House P; Layfield L; Shelton C
    J Neurosurg; 2004 Mar; 100(3):488-97. PubMed ID: 15035285
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A meta-analysis of different von Hippel Lindau mutations: are they related to retinal capillary hemangioblastoma?
    Azimi F; Aghajani A; Khakpour G; Chaibakhsh S
    Mol Genet Genomics; 2022 Nov; 297(6):1615-1626. PubMed ID: 36006455
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Genetics and angiogenesis: the example of von Hippel-Lindau disease].
    Richard S; Ladroue C; Gad S; Giraud S; Gardie B;
    Bull Cancer; 2007 Jul; 94 Spec No():S170-9. PubMed ID: 17846002
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Upregulation of hypoxia-inducible factors and autophagy in von Hippel-Lindau-associated retinal hemangioblastoma.
    Wang Y; Abu-Asab MS; Shen D; Zhuang Z; Chew EY; Chan CC
    Graefes Arch Clin Exp Ophthalmol; 2014 Aug; 252(8):1319-27. PubMed ID: 24859386
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinicopathological study of vascular endothelial growth factor (VEGF), p53, and proliferative potential in familial von Hippel-Lindau disease and sporadic hemangioblastomas.
    Miyagami M; Katayama Y; Nakamura S
    Brain Tumor Pathol; 2000; 17(3):111-20. PubMed ID: 11310918
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genotype-phenotype analysis of von Hippel-Lindau syndrome in Korean families: HIF-α binding site missense mutations elevate age-specific risk for CNS hemangioblastoma.
    Lee JS; Lee JH; Lee KE; Kim JH; Hong JM; Ra EK; Seo SH; Lee SJ; Kim MJ; Park SS; Seong MW
    BMC Med Genet; 2016 Jul; 17(1):48. PubMed ID: 27439424
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypoxia mediated expression of stem cell markers in VHL-associated hemangioblastomas.
    Ponnaluri VK; Vavilala DT; Prakash S; Mukherji M
    Biochem Biophys Res Commun; 2013 Aug; 438(1):71-7. PubMed ID: 23872148
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Extraneuraxial hemangioblastoma: A clinicopathologic study of 10 cases with molecular analysis of the VHL gene.
    Muscarella LA; Bisceglia M; Galliani CA; Zidar N; Ben-Dor DJ; Pasquinelli G; la Torre A; Sparaneo A; Fanburg-Smith JC; Lamovec J; Michal M; Bacchi CE
    Pathol Res Pract; 2018 Aug; 214(8):1156-1165. PubMed ID: 29941223
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Von Hippel-Lindau disease: a single gene, several hereditary tumors.
    Crespigio J; Berbel LCL; Dias MA; Berbel RF; Pereira SS; Pignatelli D; Mazzuco TL
    J Endocrinol Invest; 2018 Jan; 41(1):21-31. PubMed ID: 28589383
    [TBL] [Abstract][Full Text] [Related]  

  • 30. von Hippel-Lindau syndrome.
    Chou A; Toon C; Pickett J; Gill AJ
    Front Horm Res; 2013; 41():30-49. PubMed ID: 23652669
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Case report: a synonymous VHL mutation (c.414A > G, p.Pro138Pro) causes pathogenic familial hemangioblastoma through dysregulated splicing.
    Liu F; Calhoun B; Alam MS; Sun M; Wang X; Zhang C; Haldar K; Lu X
    BMC Med Genet; 2020 Feb; 21(1):42. PubMed ID: 32106822
    [TBL] [Abstract][Full Text] [Related]  

  • 32. von Hippel-Lindau disease.
    Couch V; Lindor NM; Karnes PS; Michels VV
    Mayo Clin Proc; 2000 Mar; 75(3):265-72. PubMed ID: 10725953
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intronic mutation of the VHL gene associated with central nervous system hemangioblastomas in two Chinese families with Von Hippel-Lindau disease: case report.
    Liu Z; Zhou J; Li L; Yi Z; Lu R; Li C; Gong K
    BMC Med Genet; 2020 Oct; 21(1):191. PubMed ID: 33004005
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genotype-phenotype correlation in von Hippel-Lindau disease with retinal angiomatosis.
    Wong WT; Agrón E; Coleman HR; Reed GF; Csaky K; Peterson J; Glenn G; Linehan WM; Albert P; Chew EY
    Arch Ophthalmol; 2007 Feb; 125(2):239-45. PubMed ID: 17296901
    [TBL] [Abstract][Full Text] [Related]  

  • 35. von Hippel-Lindau disease type 2A in a family with a duplicated 21-base-pair in-frame insertion mutation in the VHL gene.
    Miyagawa Y; Nakazawa M; Noda Y; Ito S; Ohguro H
    Graefes Arch Clin Exp Ophthalmol; 2003 Mar; 241(3):241-4. PubMed ID: 12644949
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Von Hippel-Lindau syndrome. A pleomorphic condition.
    Friedrich CA
    Cancer; 1999 Dec; 86(11 Suppl):2478-82. PubMed ID: 10630173
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinicopathologic study of von Hippel-Lindau syndrome-related and sporadic hemangioblastomas of central nervous system].
    Zhou J; Li NY; Zhou XJ; Zhou HB; Wu B; Jiang SJ; Ma HH; Zhang RS
    Zhonghua Bing Li Xue Za Zhi; 2010 Mar; 39(3):145-50. PubMed ID: 20450758
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Difference in CXCR4 expression between sporadic and VHL-related hemangioblastoma.
    Kruizinga RC; van Marion DM; den Dunnen WF; de Groot JC; Hoving EW; Oosting SF; Timmer-Bosscha H; Derks RP; Cornelissen C; van der Luijt RB; Links TP; de Vries EG; Walenkamp AM
    Fam Cancer; 2016 Oct; 15(4):607-16. PubMed ID: 26920352
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ocular clusterin expression in von Hippel-Lindau disease.
    Zhou M; Shen D; Head JE; Chew EY; Chévez-Barrios P; Green WR; Chan CC
    Mol Vis; 2007 Nov; 13():2129-36. PubMed ID: 18079682
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Von Hippel-Lindau disease.
    Sano T; Horiguchi H
    Microsc Res Tech; 2003 Feb; 60(2):159-64. PubMed ID: 12539169
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.